“zolgensma” Archives

in
Entry Author Date Location
Roche Enlists Dyno to Bring AI to Next-Generation Liver, CNS Gene Therapies 10/14/20 Boston
Bio Roundup: Grail Acquisition, Libra’s Launch, Tau Trial Results & More 09/25/20 National
Astellas Reports Third Patient Death in Audentes Gene Therapy Study 08/21/20 San Francisco
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy 08/07/20 National
Bio Roundup: mRNA Vaccine Data, Rise of Rallybio, Roche’s Protein Play & More 05/22/20 National
Bio Roundup: Biotech Billions, COVID-19 R&D, Zolgensma’s Path & More 04/03/20 National
A Baby’s Milestones and the Next Steps for Novartis in Gene Therapy 03/31/20 Raleigh Durham
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019 02/12/20 National
Stemonix, Atomwise Team Up on Drug Discovery With MicroOrgans and AI 12/03/19 San Diego
Roche Challenger to Biogen’s SMA Drug Succeeds in Pivotal Study 11/11/19 National
Biotech Roundup: Novartis on Hold, AMAG Vote, Neuro News & More 11/01/19 National
FDA Halts Novartis Gene Therapy Study Amid Animal Safety Concerns 10/30/19 National
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More 09/27/19 National
Drug Pricing: Innovation, Investment, and the Public Good 09/24/19 Boston
Bio Roundup: Pelosi’s Reveal, Alder’s Deal, Biogen’s Fails & More 09/20/19 National
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More 08/23/19 National
Bio Roundup: Zolgensma Fallout, Duchenne Redux, Ebola Boost & More 08/16/19 National
Bio Roundup: Surprise News, a Gene Therapy Mess & a CAR-T Step 08/09/19 National
FDA: Despite “Manipulated” Data, $2M Gene Therapy Should Stay on Market 08/06/19 National
Amicus Offers First Look At Gene Therapy Work With Batten’s Data 08/01/19 New York
Bio Roundup: Leiden’s Exit, Depression Data, a New Pricing Bill & More 07/26/19 National
Bio Roundup: Opioid Exposé, Gilead’s Gambit, Life Science IPOs & More 07/19/19 National
Bio Roundup: Duchenne Race, Warren v. Gottlieb, A $599 Genome & More 07/05/19 National
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits 06/26/19 San Francisco
Locana, Fueled With $55M, Looks to Develop Fixes for Faulty RNA 06/21/19 San Diego
Bluebird Bio Sets $1.8M Price on Gene Therapy for Rare Blood Disease 06/14/19 Boston
Bio Roundup: Opioids in Court, IPO Parade, Brain Cancer Bet & More 05/31/19 National
With Sliver of Data, BioMarin to Seek OK for Hemophilia Gene Therapy 05/28/19 San Francisco
Second US Gene Therapy, Approved for Rare Muscle Disease, to Cost $2M 05/24/19 National
Bio Roundup: Zolgensma Watch, Brain Cancer Blues, Peloton Payout & More 05/24/19 National
Page 1 of 2 next page »